The evidence for expanded use of pharmacogenetic data to help inform heart medication prescribing just got stronger. A comprehensive review of the scientific literature on pharmacogenomics and heart medications found…
Read More
New research offers more evidence for the connection between CYP2C9 and VKORC1 variants and increased bleeding risk in patients taking warfarin. A large-scale study published in the March edition of…
Read More
A new meta-analysis of clinical trials scrutinizing warfarin dosing methods found that warfarin treatment guided by individual genotypes reduced instances of serious bleeding by more than half compared to standard…
Read More
